Table 3 Multivariate Survival Analysis on factors affecting the risk of ESKD or death

Gender (male)

1.23

0.77–1.97

0.395

Age at diagnosis (years)

1.02

1.00–1.03

0.043

CKD stage at diagnosis (G2 compared to G1)

2.40

1.10–5.23

0.028

CKD stage at diagnosis (G3a compared to G1)

4.64

1.87–11.50

 < 0.001

CKD stage at diagnosis (G3b compared to G1)

8.49

3.56–20.25

 < 0.001

CKD stage at diagnosis (G4 compared to G1)

13.72

5.57–33.79

 < 0.001

CKD stage at diagnosis (G5 compared to G1)

27.90

6.42–121.22

 < 0.001

Proteinuria at diagnosis (g/24 h)

1.17

1.08–1.27

 < 0.001

Hematuria at diagnosis (yes)

1.05

0.38–2.93

0.920

Systolic blood pressure at diagnosis (mm Hg)

1.01

0.99–1.02

0.279

Diastolic blood pressure at diagnosis (mm Hg)

0.98

0.95–1.00

0.084

Use of RAAS inhibitor during follow-up (yes)

0.69

0.43–1.12

0.138

Use of immunosuppression during follow-up (yes)

1.28

0.77–2.12

0.335